Latest news
‘Pure insanity’—Elon Musk details SpaceX’s plan to turn the moon into its newest manufacturing site - FortuneFortune · Thu, 06 Aug 2026 17:36:00 GMTGrace Therapeutics Says FDA Minutes Confirm No Clinical Safety or Efficacy Deficiencies in GTx-104 Review, Advances Dual-Source Manufacturing Plan Toward NDA Resubmission - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 07:00:00 GMT